vatalanib has been researched along with ps1145 in 1 studies
| Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (ps1145) | Trials (ps1145) | Recent Studies (post-2010) (ps1145) |
|---|---|---|---|---|---|
| 276 | 42 | 98 | 54 | 1 | 25 |
| Protein | Taxonomy | vatalanib (IC50) | ps1145 (IC50) |
|---|---|---|---|
| Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | 0.1646 | |
| Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | 0.1 | |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | 1.1 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1 | |
| Serine/threonine-protein kinase pim-3 | Homo sapiens (human) | 0.88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KC; Hayashi, T; Hideshima, T | 1 |
1 review(s) available for vatalanib and ps1145
| Article | Year |
|---|---|
Novel therapies for multiple myeloma.
Topics: 2-Methoxyestradiol; Angiogenesis Inhibitors; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Cells; Enzyme Inhibitors; Estradiol; Heterocyclic Compounds, 3-Ring; Humans; Multiple Myeloma; NF-kappa B; Oxides; Phthalazines; Protease Inhibitors; Protein-Tyrosine Kinases; Pyridines; Thalidomide | 2003 |